News Shire launches potential blockbuster dry eye drug in US Xiidra could be ophthalmology blockbuster.
News Genzyme and AZ fall foul of UK pharma code Companies named in adverts after breaching code of practice.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
